Skip to main content
Log in

Acute conversion of persistent atrial fibrillation during dofetilide loading does not predict long-term atrial fibrillation-free survival

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

Purpose

Pharmacologic conversion of atrial fibrillation and flutter (AF/AFl) is common with dofetilide. We determined whether pharmacologic conversion with dofetilide predicts long-term arrhythmia-free survival.

Methods

We retrospectively studied a cohort of 264 consecutive patients who initiated dofetilide during persistent AF/AFl between 2008 and 2013. Patients were excluded if dofetilide was discontinued prior to five doses or electrical cardioversion was performed prior to four doses. Incidence of and characteristics associated with pharmacologic conversion were determined. Patients were followed for long-term AF/AFl recurrence. Predictors of recurrence were identified using multivariate Cox modeling.

Results

Of 205 patients meeting study criteria, 92 (44.9 %) converted to sinus rhythm during dofetilide loading. Female gender, history of AFl, greater number of prior catheter ablations, shorter duration of current AF/AFl, and presentation in AFl were all associated with acute pharmacologic conversion (p = 0.001, 0.05, 0.001, 0.003, and 0.003, respectively). In multivariate modeling, longer time since first AF/AFl diagnosis (hazard ratio (HR) = 1.07 per 1-year increase, 95 % confidence interval (CI) 1.03–1.10, p < 0.001), longer duration of current AF/AFl episode (HR = 1.01 per 1-month increase, 95 % CI 1.00–1.01, p = 0.003) and greater number of failed antiarrhythmic drugs (HR = 1.43 per one drug increase, 95 % CI 1.20–1.70, p < 0.001) were independently associated with shorter time to AF/AFl recurrence. Pharmacologic conversion was not significantly associated with time to AF/AFl recurrence (HR = 0.79, 95 % CI 0.57–1.10, p = 0.2).

Conclusions

Acute pharmacologic conversion of persistent AF/AFl to sinus rhythm frequently occurs during dofetilide loading. Nevertheless, acute pharmacologic conversion does not predict long-term arrhythmia control, which was moderate at best.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

AF:

Atrial fibrillation

AFl:

Atrial flutter

References

  1. Corley, S. D., Epstein, A. E., DiMarco, J. P., Domanski, M. J., Geller, N., Greene, H. L., et al. (2004). Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation, 109(12), 1509–1513.

    Article  PubMed  Google Scholar 

  2. Stewart, S., Hart, C. L., Hole, D. J., & McMurray, J. J. (2002). A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. The American Journal of Medicine, 113(5), 359–364.

    Article  PubMed  Google Scholar 

  3. Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1987). Atrial fibrillation: a major contributor to stroke in the elderly. the Framingham Study. Archives of Internal Medicine, 147(9), 1561–1564.

    Article  CAS  PubMed  Google Scholar 

  4. Baman, T. S., Ilg, K. J., Gupta, S. K., Good, E., Chugh, A., Jongnarangsin, K., et al. (2010). Mapping and ablation of epicardial idiopathic ventricular arrhythmias from within the coronary venous system. Circulation. Arrhythmia and Electrophysiology, 3(3), 274–279.

    Article  PubMed  Google Scholar 

  5. Savelieva, I., & Camm, J. (2008). Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches. Europace, 10(6), 647–665.

    Article  PubMed  Google Scholar 

  6. Singh, B. N., Singh, S. N., Reda, D. J., Tang, X. C., Lopez, B., Harris, C. L., et al. (2005). Amiodarone versus sotalol for atrial fibrillation. The New England Journal of Medicine, 352(18), 1861–1872.

    Article  CAS  PubMed  Google Scholar 

  7. Singh, S., Zoble, R. G., Yellen, L., Brodsky, M. A., Feld, G. K., Berk, M., et al. (2000). Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study. Circulation, 102(19), 2385–2390.

    Article  CAS  PubMed  Google Scholar 

  8. Pedersen, O. D., Bagger, H., Keller, N., Marchant, B., Kober, L., & Torp-Pedersen, C. (2001). Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy. Circulation, 104(3), 292–296.

    Article  CAS  PubMed  Google Scholar 

  9. Banchs, J. E., Wolbrette, D. L., Samii, S. M., Penny-Peterson, E. D., Patel, P. P., Young, S. K., et al. (2008). Efficacy and safety of dofetilide in patients with atrial fibrillation and atrial flutter. Journal of Interventional Cardiac Electrophysiology, 23(2), 111–115.

    Article  PubMed  Google Scholar 

  10. Cotiga, D., Arshad, A., Aziz, E., Joshi, S., Koneru, J. N., & Steinberg, J. S. (2007). Acute conversion of persistent atrial fibrillation during dofetilide initiation. Pacing and Clinical Electrophysiology : PACE, 30(12), 1527–1530.

    Article  PubMed  Google Scholar 

  11. Prystowsky, E. N., Freeland, S., Branyas, N. A., Rardon, D. P., Fogel, R. I., Padanilam, B. J., et al. (2003). Clinical experience with dofetilide in the treatment of patients with atrial fibrillation. Journal of Cardiovascular Electrophysiology, 14(12 Suppl), S287–S290.

    Article  PubMed  Google Scholar 

  12. Calkins, H., Kuck, K. H., Cappato, R., Brugada, J., Camm, A. J., Chen, S. A., et al. (2012). 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm, 9(4), 632–696. e621.

    Article  PubMed  Google Scholar 

  13. Tikosyn(R) [package insert]. Pfizer Inc., New York, NY; January 2014. http://labeling.pfizer.com/ShowLabeling.aspx?id=639. Accessed 29 Apr 2014.

  14. Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001). Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA, 285(22), 2864–2870.

    Article  CAS  PubMed  Google Scholar 

  15. Borgeat, A., Goy, J. J., Maendly, R., Kaufmann, U., Grbic, M., & Sigwart, U. (1986). Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm. The American Journal of Cardiology, 58(6), 496–498.

    Article  CAS  PubMed  Google Scholar 

  16. Bianconi, L., Mennuni, M., Lukic, V., Castro, A., Chieffi, M., & Santini, M. (1996). Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study. Journal of the American College of Cardiology, 28(3), 700–706.

    Article  CAS  PubMed  Google Scholar 

  17. Di Benedetto, S. (1997). Quinidine versus propafenone for conversion of atrial fibrillation to sinus rhythm. The American Journal of Cardiology, 80(4), 518–519.

    Article  PubMed  Google Scholar 

  18. Kochiadakis, G. E., Igoumenidis, N. E., Solomou, M. C., Kaleboubas, M. D., Chlouverakis, G. I., & Vardas, P. E. (1999). Efficacy of amiodarone for the termination of persistent atrial fibrillation. The American Journal of Cardiology, 83(1), 58–61.

    Article  CAS  PubMed  Google Scholar 

  19. Kerin, N. Z., Faitel, K., & Naini, M. (1996). The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Amiodarone vs quinidine for conversion of atrial fibrillation. Archives of Internal Medicine, 156(1), 49–53.

    Article  CAS  PubMed  Google Scholar 

  20. Tieleman, R. G., Gosselink, A. T., Crijns, H. J., van Gelder, I. C., van den Berg, M. P., de Kam, P. J., et al. (1997). Efficacy, safety, and determinants of conversion of atrial fibrillation and flutter with oral amiodarone. The American Journal of Cardiology, 79(1), 53–57.

    Article  CAS  PubMed  Google Scholar 

  21. Singh, S., Saini, R. K., DiMarco, J., Kluger, J., Gold, R., & Chen, Y. W. (1991). Efficacy and safety of sotalol in digitalized patients with chronic atrial fibrillation. The Sotalol Study Group. The American Journal of Cardiology, 68(11), 1227–1230.

    Article  CAS  PubMed  Google Scholar 

  22. Hohnloser, S. H., van de Loo, A., & Baedeker, F. (1995). Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine. Journal of the American College of Cardiology, 26(4), 852–858.

    Article  CAS  PubMed  Google Scholar 

  23. Crijns, H. J., Van Gelder, I. C., Van Gilst, W. H., Hillege, H., Gosselink, A. M., & Lie, K. I. (1991). Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter. The American Journal of Cardiology, 68(4), 335–341.

    Article  CAS  PubMed  Google Scholar 

  24. Crijns, H. J., Gosselink, A. T., & Lie, K. I. (1996). Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: a randomized, double-blind study. PRODIS Study Group. Cardiovascular Drugs and Therapy/sponsored by the International Society of Cardiovascular Pharmacotherapy, 10(2), 145–152.

    Article  CAS  PubMed  Google Scholar 

  25. Le Heuzey, J. Y., De Ferrari, G. M., Radzik, D., Santini, M., Zhu, J., & Davy, J. M. (2010). A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study. Journal of Cardiovascular Electrophysiology, 21(6), 597–605.

    Article  PubMed  Google Scholar 

  26. Pamukcu, B., & Lip, G. Y. (2010). Dronedarone or amiodarone for rhythm control for atrial fibrillation: implications from the DIONYSOS study. Expert Opinion on Pharmacotherapy, 11(17), 2775–2778.

    Article  CAS  PubMed  Google Scholar 

  27. Feld, G. K., & Cha, Y. (1997). Electrophysiologic effects of the new class III antiarrhythmic drug dofetilide in an experimental canine model of pacing-induced atrial fibrillation. Journal of Cardiovascular Pharmacology and Therapeutics, 2(3), 195–203.

    Article  CAS  PubMed  Google Scholar 

  28. Malhotra, R., Bilchick, K. C., & DiMarco, J. P. (2014). Usefulness of pharmacologic conversion of atrial fibrillation during dofetilide loading without the need for electrical cardioversion to predict durable response to therapy. The American Journal of Cardiology, 113(3), 475–479.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Wijffels, M. C., Kirchhof, C. J., Dorland, R., & Allessie, M. A. (1995). Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation, 92(7), 1954–1968.

    Article  CAS  PubMed  Google Scholar 

  30. Morillo, C. A., Klein, G. J., Jones, D. L., & Guiraudon, C. M. (1995). Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation, 91(5), 1588–1595.

    Article  CAS  PubMed  Google Scholar 

  31. Manning, W. J., Silverman, D. I., Katz, S. E., Riley, M. F., Come, P. C., Doherty, R. M., et al. (1994). Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. Journal of the American College of Cardiology, 23(7), 1535–1540.

    Article  CAS  PubMed  Google Scholar 

  32. Frustaci, A., Chimenti, C., Bellocci, F., Morgante, E., Russo, M. A., & Maseri, A. (1997). Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation, 96(4), 1180–1184.

    Article  CAS  PubMed  Google Scholar 

  33. Allessie, M., Ausma, J., & Schotten, U. (2002). Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovascular Research, 54(2), 230–246.

    Article  CAS  PubMed  Google Scholar 

  34. Everett, T. H., Wilson, E. E., Verheule, S., Guerra, J. M., Foreman, S., & Olgin, J. E. (2006). Structural atrial remodeling alters the substrate and spatiotemporal organization of atrial fibrillation: a comparison in canine models of structural and electrical atrial remodeling. American Journal of Physiology. Heart and Circulatory Physiology, 291(6), H2911–H2923.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported in part by the F. Harlan Batrus Research Fund and the Susan and Murray Bloom Fund.

Author contributions

Khurshid—design, data collection and analysis, drafting, and approval of article

Akerman—design, data collection, and approval of article

Man—design, data collection, and approval of article

Supple—critical revision and approval of article

Dixit—critical revision and approval of article

Epstein—critical revision and approval of article

Marchlinski—critical revision and approval of article

Frankel—design, data collection and analysis, drafting, and approval of article

Conflict of interest

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shaan Khurshid.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khurshid, S., Akerman, S., Man, J.P. et al. Acute conversion of persistent atrial fibrillation during dofetilide loading does not predict long-term atrial fibrillation-free survival. J Interv Card Electrophysiol 42, 117–124 (2015). https://doi.org/10.1007/s10840-015-9974-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-015-9974-7

Keywords

Navigation